Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: A large, open-label study close to clinical practice Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Tumor Necrosis Factor-alpha

abstract

  • In patients with RA who were DMARD-IR/TNFi-IR, tocilizumab ± DMARDs provided rapid and sustained efficacy without unexpected safety concerns.

publication date

  • May 21, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3595980

Digital Object Identifier (DOI)

  • 10.1136/annrheumdis-2011-201087

PubMed ID

  • 22615456

Additional Document Info

start page

  • 1950

end page

  • 4

volume

  • 71

number

  • 12